Chronic lymphocytic leukaemia (CLL)

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent’s antibody drug for non-Hodgkin lymphoma.

Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood.